Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | NAMPT | P43490 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6003798 | 0.76 | ALOX15 (0.63) | ALOX15NAMPTALDH1A1USP2HSD17B10 | |
| SCHEMBL3915623 | 0.76 | ALOX15 (0.65) | ALOX15NAMPTALDH1A1HDAC6HSD17B10 | |
| SCHEMBL6002505 | 0.76 | ALOX15 (0.62) | ALOX15NAMPTALDH1A1USP2HSD17B10 | |
| SCHEMBL6004378 | 0.73 | ALOX15 (0.48) | ALOX15NAMPTALDH1A1CYP3A4CYP2D6 | |
| SCHEMBL6002607 | 0.72 | ALOX15 (0.65) | ALOX15NAMPTALDH1A1KMT2A | |
| SCHEMBL6004843 | 0.71 | ALOX15 (0.69) | ALOX15NAMPTALDH1A1KMT2A | |
| SCHEMBL6004193 | 0.69 | ALOX15 (0.73) | ALOX15NAMPTALDH1A1KMT2A | |
| SCHEMBL6004374 | 0.68 | ALOX15 (0.61) | ALOX15NAMPTALDH1A1USP2CYP3A4 | |
| SCHEMBL6004838 | 0.66 | ALOX15 (0.50) | ALOX15NAMPTALDH1A1KMT2A | |
| SCHEMBL3710724 | 0.66 | NAMPT (1.00) | NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060183780-A1 | Pyrazole compounds useful in the treatment of inflammation | BIOLIPOX AB (SE) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183780-A1 | Pyrazole compounds useful in the treatment of inflammation | ALOX15, ALOX12, ALOX15B | ALOX15 1/4885NAMPT 1461/4885ALDH1A1 763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.